Skip to main content
Mercedes Porosnicu, MD, Oncology, Winston Salem, NC, Wake Forest Baptist Health-Lexington Medical Center

MercedesPorosnicuMD

Oncology Winston Salem, NC

Professor of Internal Medicine, Section on Hematology and Oncology Wake Forest School of Medicine

Dr. Porosnicu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Porosnicu's full profile

Already have an account?

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1998 - 2001
  • SUNY Health Science Center at Brooklyn
    SUNY Health Science Center at BrooklynResidency, Internal Medicine, 1996 - 1998
  • University of Medicine and Pharmacy ‘Gr T Popa” Iasi
    University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1987

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2006 - 2024
  • FL State Medical License
    FL State Medical License 2002 - 2008

Awards, Honors, & Recognition

  • Nominated for NIH -P30 Clinical Investigator Team Leadership Supplemental Award WFU CCCWFU, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
  • Nominated Graduate Faculty Translational Science Institute WFU, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leu...  
    Nimmanapalli R, Porosnicu M, Nguyen D, Worthington E, O'Bryan E, Perkins C, Bhalla K, Clin Cancer Res, 1/1/2001

Abstracts/Posters

  • Retrospective Analysis of Cisplatin Nephrotoxicity in Head and Neck Cancer Patients Treated as Outpatient with Concurrent High-Dose Cisplatin and Radiotherapy
    M. Haughton, MD, J. Faig, M, R. B. D'Agostino, PhD, M. J. Whelan, MPH, M. Murea, MD, M. Porosnicu, MD, Multidisciplinary Head and Neck Symposium, 1/1/2014
  • Phase I Clinical Trial of Re-irradiation with Pemetrexed and Erlotinib followed by Maintenance Erlotinib for Recurrent and Second Primary Squamous Cell Carcinoma of th...
    M. Porosnicu, MD, K. Greven, MD, N. Hayes, MD, B. Chera, MD, C. Sullivan, MD, J. D. Waltonen, MD, J. D. Browne, MD, Multidisciplinary Head and Neck Symposium, 1/1/2014
  • Retrospective Analysis of the Impact of HPV Status and Smoking on Mucositis in Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Concurrent Chemotherapy...
    M. Porosnicu, MD, M. Vatca, MD; J.T. Lucas, Jr., MS, MD, J. Laudadio, MD; R.B. D’Agostino, Jr., PhD; J.D. Waltonen, MD; C.A. Sullivan, MD; R. Rouchard-Plasser, PA-C; M..., Multidisciplinary Head and Neck Symposium, 1/1/2014
  • Join now to see all

Lectures

  • Chemotherapy for Head & Neck CA 
    WFBH - 1/1/2016
  • Special Care Dentistry 
    Washington, DC - 1/1/2009
  • Treatment of Squamous Cell Carcinoma of the Head and Neck 
    Watauga Medical Center in Boone - 1/1/2009
  • Join now to see all

Hospital Affiliations